Brief: Verrica Pharmaceuticals Q4 basic EPS USD -0.53
29/02/2024 12:36
Feb 29 (Reuters) - Verrica Pharmaceuticals Q4 basic EPS USD -0.53. * Q4 income from operations USD -23.136 million * Q4 collaboration revenue USD 1.866 million * Q4 net income USD -24.614 million
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data